These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33852927)

  • 41. Prospective Cross-Sectional Study of Quality of Life of Vitiligo Patients Using a Vitiligo Specific Quality of Life Instrument.
    Anaba EL; Oaku RI
    West Afr J Med; 2020 Dec; 37(7):745-749. PubMed ID: 33296482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitiligo and lupus: more similarities than meets the eye.
    Speeckaert R; van Geel N
    Br J Dermatol; 2017 Nov; 177(5):1161-1162. PubMed ID: 29192988
    [No Abstract]   [Full Text] [Related]  

  • 43. Noticeability of vitiligo is in the eye of the beholder.
    Pandya AG; Ezzedine K
    Br J Dermatol; 2022 Oct; 187(4):461-462. PubMed ID: 35905981
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia.
    Bin Saif GA; Al-Balbeesi AO; Binshabaib R; Alsaad D; Kwatra SG; Alzolibani AA; Yosipovitch G
    Am J Clin Dermatol; 2013 Dec; 14(6):489-95. PubMed ID: 23839260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitiligo-specific instrument on quality of life - Brazilian Portuguese version.
    Boza JC; Giongo NP; Cestari TF
    An Bras Dermatol; 2016; 91(6):865-866. PubMed ID: 28099626
    [No Abstract]   [Full Text] [Related]  

  • 47. Association of Quality of Life and Location of Lesions in Patients With Vitiligo.
    Florez-Pollack S; Jia G; Zapata L; Rodgers C; Hernandez K; Hynan LS; Pandya AG
    JAMA Dermatol; 2017 Mar; 153(3):341-342. PubMed ID: 28097309
    [No Abstract]   [Full Text] [Related]  

  • 48. High Frequency of Photosensitizers in Products Marketed Online for Vitiligo.
    Brown AM; Ahmed A
    Dermatitis; 2022 Mar-Apr 01; 33(2):e16-e18. PubMed ID: 35170521
    [No Abstract]   [Full Text] [Related]  

  • 49. Is Fas-mediated apoptosis of melanocytes indispensable in vitiligo?
    Schmitz J; Böhm M
    Exp Dermatol; 2022 Feb; 31(2):261-262. PubMed ID: 34396580
    [No Abstract]   [Full Text] [Related]  

  • 50. Measurement of vitiligo: human vs. machine.
    Edwards C
    Br J Dermatol; 2019 May; 180(5):991. PubMed ID: 31025746
    [No Abstract]   [Full Text] [Related]  

  • 51. Excimer laser in vitiligo: where there is light, there is hope.
    Silpa-Archa N; Lim HW; Wongpraparut C
    Br J Dermatol; 2019 Jul; 181(1):21-22. PubMed ID: 31259412
    [No Abstract]   [Full Text] [Related]  

  • 52. [Differential functional diagnosis of vitiligo, depigmentosis, leukoderma].
    HALTER K
    Dermatol Wochenschr; 1952; 125(1):1-6. PubMed ID: 14926412
    [No Abstract]   [Full Text] [Related]  

  • 53. Quality of life in patients with vitiligo using the Short Form-36.
    Yang Y; Zapata L; Rodgers C; Hernandez K; Iyer M; Jia G; Hynan LS; Pandya AG
    Br J Dermatol; 2017 Dec; 177(6):1764-1766. PubMed ID: 28872663
    [No Abstract]   [Full Text] [Related]  

  • 54. A Randomized Double Blind Clinical Trial on a Sabgh Formulation for Patients With Vitiligo.
    Hosseinkhani A; Montaseri H; Sodaifi M; Mohagheghzadeh A; Seradj H; Afshari-Jouybari H
    J Evid Based Complementary Altern Med; 2015 Oct; 20(4):254-8. PubMed ID: 25851025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determining the minimal important change scores of the Vitiligo Impact Scale (VIS)-22 and Dermatology Life Quality Index (DLQI) scores in Indian patients with vitiligo using anchor- and distribution-based approaches.
    Gupta V; Taneja N; Sati HC; Sreenivas V; Ramam M
    Br J Dermatol; 2020 Aug; 183(2):393-394. PubMed ID: 32119113
    [No Abstract]   [Full Text] [Related]  

  • 56. Vitiligo on YouTube: A cross-sectional analysis.
    Carrington AE; Kitts S; Kleinwaks E; Luu J; Nguyen M; Park JH
    J Am Acad Dermatol; 2022 Jan; 86(1):199-201. PubMed ID: 33508386
    [No Abstract]   [Full Text] [Related]  

  • 57. Measuring the Impact of Vitiligo: Behind the White Spots.
    Speeckaert R; Lambert J; van Geel N
    J Invest Dermatol; 2016 Jan; 136(1):6-7. PubMed ID: 26763415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nylon watchband causing local leukoderma (vitiligo)].
    HOFFMANN E
    Arztl Wochensch; 1956 Aug; 11(33):732-4. PubMed ID: 13354559
    [No Abstract]   [Full Text] [Related]  

  • 59. Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index.
    Bae JM; Zubair R; Ju HJ; Kohli I; Lee HN; Eun SH; Lyons AB; Vellaichamy G; Han TY; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2022 Feb; 86(2):387-393. PubMed ID: 34246695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between vitiligo extent and distribution and quality-of-life impairment.
    Silverberg JI; Silverberg NB
    JAMA Dermatol; 2013 Feb; 149(2):159-64. PubMed ID: 23560296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.